Alphatec Holdings (Alphatec Holdings) Days Sales Outstanding

: 45.35 (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

Alphatec Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was $68.6 Mil. Alphatec Holdings's Revenue for the three months ended in Dec. 2023 was $138.0 Mil. Hence, Alphatec Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 45.35.

The historical rank and industry rank for Alphatec Holdings's Days Sales Outstanding or its related term are showing as below:

ATEC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.37 Med: 56.29 Max: 96.59
Current: 48.37

During the past 13 years, Alphatec Holdings's highest Days Sales Outstanding was 96.59. The lowest was 48.37. And the median was 56.29.

ATEC's Days Sales Outstanding is ranked better than
71.38% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.7 vs ATEC: 48.37

Alphatec Holdings's Days Sales Outstanding declined from Dec. 2022 (47.71) to Dec. 2023 (45.35).

Alphatec Holdings Days Sales Outstanding Historical Data

The historical data trend for Alphatec Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphatec Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

50.27

49.99

49.09

53.03

50.21

Alphatec Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															47.71	51.21	47.74	48.01	45.35

Competitive Comparison

For the Medical Devices subindustry, Alphatec Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alphatec Holdings Days Sales Outstanding Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Alphatec Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Alphatec Holdings's Days Sales Outstanding falls into.

Alphatec Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Alphatec Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (60.06	+	72.613)	/	2 )	/	482.262	*	365
=	66.3365					/	482.262	*	365
=	50.21

Alphatec Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (64.519	+	72.613)	/	2 )	/	137.97	*	365 / 4
=	68.566					/	137.97	*	365 / 4
=	45.35

Alphatec Holdings (NAS:ATEC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Alphatec Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Alphatec Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Alphatec Holdings (Alphatec Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alphatec Holdings Inc (NAS:ATEC) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

L1Z1:Germany

Address

1950 Camino Vida Roble, Carlsbad, CA, USA, 92008

Website

https://www.atecspine.com

Alphatec Holdings Inc is a medical technology company focused on the design, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Executives

David Sponsel	officer: EVP, Sales	C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
David M Demski	director	C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Patrick Miles	director, officer: Executive Chairman	7475 LUSK BLVD., SAN DIEGO CA 92121
Tullis James L L	director, 10 percent owner	100 FIRST STAMFORD PLACE, STAMFORD CT 06907
David H Mowry	director	9775 TOLEDO, IRVINE CA 92618
Evan Bakst	director	225 CENTRAL PARK WEST, APT. 1605, NEW YORK NY 10024
Jennifer N. Pritzker	10 percent owner	C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Tyson Eliot Marshall	officer: GENERAL COUNSEL & CORP. SEC.	10680 TREENA STREET, SUITE 500, SAN DIEGO CA 92131
Craig E Hunsaker	officer: See Remarks	C/O ALPHATEC HOLDINGS, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Paul Segal	10 percent owner	1700 BROADWAY, 35TH FLOOR, NEW YORK NY 10019
L-5 Healthcare Partners, Llc	10 percent owner, other: Director by deputization	1700 BROADWAY, 35TH FLOOR, NEW YORK NY 10019
John Todd Koning	officer: Chief Financial Officer	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
David R Pelizzon	director, 10 percent owner	2850 FRONTIER DR, WARSAW IN 46582
Scott Lish	officer: SVP, Development	C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008